Beta Thalesemia Treatment

Treatment Thalassemia Major

Blood Transfusion: Hypertrasnfusion protocol. Washed packed cells or leucodepleted packed calls.

Chelation Therapy: Desferoxamine, Deferiprone, Deferasirox.

Monitoring and treatment of complications: Endocrine complications, cardiac complications, infections, Blood transfusion reaction all needs a life time heamo-vigilance to decrease the incidence of mortality and morbidity and ultimately improves the survival and quality of life.

Treatment modalities related to Thalassemia Intermedia

  • Non-Transfused Thalassemia intermedia (NTTI)
  • Transfusion dependent Thalassemia Intermedia (NTTI)

Non-Transfused Thalassemia intermedia (NTTI)

A baseline red blood cell phenotype should be obtained from patients, who should then be seen at a thalassemia center every three to six months, with attention to overall clinical well-being. Following parameters should be monitored: Growth and development, cardiopulmonary assessment, pulmonary hypertension, extramedullary hematopoiesis.

When to start regular transfusion in (NTTI):

  • On the basis of following parameters
  • Clinical and Lab Assessment
  • Symptomatic anemia
  • Poor school performance
  • Falling Growth velocity
  • Delayed puberty
  • Extramedullary hematopoiesis
  • Leg ulcers
  • Pulmonary hypertension
  • Thrombosis
  • Hypersplensim

When to plan splenectomy in (NTTI):

  • Massive splenomegaly
  • Hypersplenism or unable to receive transfusions

Transfusion dependent Thalassemia intermedia (TDTI)

  • Regular folic acid
  • Chelation if required
  • Regular echo
  • Growth and pubertal assessment
  • Transfusion if indicated
  • Extramedullary Haemopoiesis chest or spine .Radiation therapy if symptomatic.
  • Hydroxyurea
how can we help you?

Contact us at the AMTF office or submit a Inquiry form online.

#AMTF Blood Donation Camp at Amreli Steels (Dhabeji Unit)
April 24, 2019
... See MoreSee Less

View on Facebook

Ms. Fariya Zameen (Head of Marketing) & Mr. Muhammad Azam (Head Services Marketing) from Faysal Bank visited #AMTF
April 24, 2019
... See MoreSee Less

View on Facebook

#AMTF Thalassemia Awareness Session at Amreli Steels - Dhabeji Unit
April 23, 2019
... See MoreSee Less

View on Facebook

Ehsas Karo, Kuch Khas Karo!

... See MoreSee Less

View on Facebook

#AMTF Blood Donation Camp at Greenwich University, Karachi
April 16, 2019
... See MoreSee Less

View on Facebook

#AMTF Blood Donation Camp at PAF-KIET, Nazimabad Campus
April 15, 2019
... See MoreSee Less

View on Facebook

#AMTF Blood Donation Camp at Institute of Business Management (IoBM)
April 9, 2019
... See MoreSee Less

View on Facebook

Dr. Asim Qidwai, Founder & CEO AMTF had a meeting with High Commissioner Pakistan at Canada Mr. Raza Bashir Tarar in Ottawa
April 4, 2019PRESS RELEASE
April 04, 2019
Dr. Asim Qidwai, Founder & C.E.O of Afzaal Memorial Thalassemia Foundation (AMTF) called on the High Commissioner of Pakistan, Raza Bashir Tarar and briefed him on the work of the Foundation in the field of health care related to children from blood disorder.
The High Commissioner appreciated the plan of the Foundation for conducting awareness sessions with the Pakistani community living abroad. He agreed with the vision of the foundation to deliver the utmost level of passionate care to the patients of thalassemia. The High Commissioner urged the founder for developing synergy among the institutes working in Pakistan on the childhood blood diseases.
Dr. Asim Qidwai also informed the High Commissioner for his drive to include thalassemia awareness and prevention in the curriculum of high schools and colleges of Pakistan.
... See MoreSee Less

View on Facebook

for donations click here